Sorrento Therapeutics Inc (SRNE)

[1776club]

Yup, but we are in Rats and then there is this; Published March 8
Dr. Marc Siegel says a new experimental pill developed to treat COVID-19 could be the "holy grail of therapeutics" used against the virus. First-stage testing of Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, showed promising signs of effectiveness in reducing the virus in patients.

What stage are we in again? Oh yea, Preclinical.
What stage are they in again?
Active, not recruiting Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
Coronavirus Disease (COVID-19)
Drug: Molnupiravir
Drug: Placebo
Phase 2
Phase 3 August 10, 2021